Stock quotes provided by InterActive Data. The gurus listed in this website are not affiliated with, LLC. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Past performance is a poor indicator of future performance. In no event shall be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on, or relating to the use of, or inability to use, or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Gurus may be added or dropped from the GuruFocus site at any time. The individuals or entities selected as 'gurus' may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. The latest trend in earnings estimate revisions might not help the stock continue moving higher in. Under no circumstances does any information posted on represent a recommendation to buy or sell a security. (PRPH) was a big mover last session on higher-than-average trading volume. This investment adviser does not provide advice to individual investors. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund.

This valuation marks a premium compared to its industry's average Forward P/E of 16.42. is not operated by a broker or a dealer. The 3 analysts offering 12-month price forecasts for Prophase Labs Inc have a median target of 14.00, with a high estimate of 15.00 and a. Looking at its valuation, ProPhase Labs, Inc. Over the past month, the Zacks Consensus EPS estimate has moved 59.26% higher.

Create real-time notifications to follow any changes in the live stock price. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. View todays ProPhase Labs Inc stock price and latest PRPH news and analysis. (Images: vectorfusionart, Adobe Stock Capaccio, Wikimedia Commons)Get ready. Our system takes these estimate changes into account and delivers a clear, actionable rating model. Weve curated a collection of lessons, hands-on activities, labs, readings. We developed the Zacks Rank to capitalize on this phenomenon. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Investors should also note any recent changes to analyst estimates for ProPhase Labs, Inc.These recent revisions tend to reflect the evolving nature of short-term business trends.

Prophase labs stock